Thomas L. Vaughan
M.P.H., University of Washington, 1983.
M.D., University of Illinois, 1978.
B.S., Cornell University, Biomedical Engineering, 1974.
For a full description of research interests and a list of publications, see research website under "contact information" above.
Association Between Markers of Obesity and Progression From Barrett's Esophagus to Esophageal Adenocarcinoma.. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.. 2013.
Epidemiology and risk factors for gastroesophageal junction tumors: understanding the rising incidence of this disease.. Seminars in radiation oncology. 23(1):3-9.. 2013.
Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus.. Nature genetics. 44(10):1131-1136.. 2012.
A Clinical Risk Prediction Model for Barrett Esophagus.. Cancer prevention research (Philadelphia, Pa.). 5(9):1115-1123.. 2012.
Non-Steroidal Anti-Inflammatory Drug Use Reduces Risk for Adenocarcinomas of the Esophagus and Esophagogastric Junction in a Pooled Analysis.. Gastroenterology. 142(3):442-452.e5.. 2012.
Use of statin medications and risk of esophageal adenocarcinoma in persons with Barrett's esophagus.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 21(3):456-461.. 2012.
Diet and the risk of head and neck cancer: a pooled analysis in the INHANCE consortium.. Cancer causes & control : CCC. 23(1):69-88.. 2012.
History of Diabetes and Risk of Head and Neck Cancer: A Pooled Analysis from the International Head and Neck Cancer Epidemiology Consortium.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 21(2):294-304.. 2012.
Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON Consortium.. International journal of epidemiology. 41(6):1706-1718.. 2012.
Hormonal factors and risks of esophageal squamous cell carcinoma and adenocarcinoma in postmenopausal women.. Cancer prevention research (Philadelphia, Pa.). 4(6):840-50.. 2011.
MUC2 is a highly specific marker of goblet cell metaplasia in the distal esophagus and gastroesophageal junction.. The American journal of surgical pathology. 35(7):1007-13.. 2011.
Principal component analysis of dietary and lifestyle patterns in relation to risk of subtypes of esophageal and gastric cancer.. Annals of epidemiology. 21(7):543-50.. 2011.
Possible association between a genetic polymorphism at 8q24 and risk of upper gastrointestinal cancer.. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP). 20(1):54-7.. 2011.
Application of biomarkers in cancer risk management: evaluation from stochastic clonal evolutionary and dynamic system optimization points of view.. PLoS computational biology. 7(2):e1001087.. 2011.
Genetic variation in the prostate stem cell antigen gene and upper gastrointestinal cancer in white individuals.. Gastroenterology. 140(2):435-41.. 2011.
Wood dust exposure and risk of lung cancer.. Occupational and environmental medicine. 68(8):599-604.. 2011.
Serum Selenium, Genetic Variation in Selenoenzymes, and Risk of Colorectal Cancer: Primary Analysis from the Women's Health Initiative Observational Study and Meta-analysis.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 20(9):1822-30.. 2011.